Large-scale testing (Phase 3)Study completedNCT02168491
What this trial is testing
Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
Who this might be right for
Type 2 Diabetes Mellitus
Medical University of Vienna 10